Leadership
Rob Treml has been elevated to Vice President, Commercial Analytics, Insights & Digital Strategy at Incyte, where he will serve as a member of the US Commercial Leadership Team across Oncology and Immunology. He previously served as Vice President of Sales, Immunology at Incyte, following a long career in commercial, sales, marketing and market access leadership. Before joining Incyte, he held leadership roles at Johnson & Johnson and AstraZeneca, building extensive experience across immunology, oncology, specialty care and rare disease.
In his new role, he will focus on commercial analytics, strategic insights and digital strategy to support Incyte’s US commercial organization. His experience spans market access, commercial operations, brand strategy, sales leadership and therapy access marketing. At Johnson & Johnson, he led Payer Strategy & Therapy Access Marketing for the Rare Disease Specialty Business Unit, while at AstraZeneca he held senior leadership positions across market access and US commercial operations, strengthening his expertise in pharmaceutical commercialization and customer-focused strategy.
CXO Tech Bot congratulates Rob Treml on the new role and wishes them continued success in this leadership journey.
